TrialBMC cancer2016

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Antonio Avallone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.